Vanberra Signal

Miist Therapeutics

Curated by Signal

Developer of advanced inhalation drug delivery system

Overview

Developer of advanced inhalation drug delivery system for people with smoking addiction. It develops inhaled therapies to free people from addiction. Its proprietary technology commercializes these treatments quickly and cost-effectively, with the potential to improve the health of millions of people.

Key facts

Founded
2019

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Developer of proprietary platform technologies for Neurological applications

    Life Sciences TechnologyCleveland, United States
  • Wearable devices to detect peripheral arterial disease

    Life Sciences TechnologyManchester, United States
  • Developer novel therapeutics to treat resistant infectious diseases and cancers using AI

    Life Sciences TechnologyNew York City, United States

About Miist Therapeutics

What does Miist Therapeutics do?

Developer of advanced inhalation drug delivery system for people with smoking addiction.

Where is Miist Therapeutics headquartered?

Miist Therapeutics is headquartered in Alameda, United States.

When was Miist Therapeutics founded?

Miist Therapeutics was founded in 2019.

Which sector is Miist Therapeutics in?

Miist Therapeutics operates in Life Sciences Technology.

Who are Miist Therapeutics's competitors?

Companies similar to Miist Therapeutics include NDI Medical, Harbor Vascular, and Lodo Therapeutics.